News & Articles

Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration

The drug candidate was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated

Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg

Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations

Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response

The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality

OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients

356-patient concordance study confirms performance using head-to-head testing vs. droplet digital PCR

Top talks presenting the latest technologies, research and applications are now available on demand

Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant

Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative

This multi-session event will take you on a weekly path of discovery, featuring the latest in IHC antibodies, histology troubleshooting techniques, case studies in pathology, and more

Novel chip-based diagnostic technology can detect individual viral antigens in nasal swab samples to identify the viruses that cause COVID-19 and flu with a single test

The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies

Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India

Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients

The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)